# Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

> **NCT00428116** · NA · TERMINATED · sponsor: **University of Washington** · enrollment: 140 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** HAART

## Key facts

- **NCT ID:** NCT00428116
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-09
- **Primary completion:** 2013-07
- **Final completion:** 2014-12
- **Target enrollment:** 140 (ACTUAL)
- **Why stopped:** DSMB recommended termination because TI was safe but not durable.
- **Last updated:** 2018-07-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00428116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00428116, "Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00428116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*